Právní předpis byl sestaven k datu 27.07.2013.
Zobrazené znění právního předpisu je účinné od 27.07.2013.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2014
195/2013 Sb.
195
XXXXXXX
Xxxxxxxxxxxx zdravotnictví
ze xxx 3. xxxxxxxx 2013
o xxxxxxxxxx složení xxxxxxxxxx xxxxx pro xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx rok 2014
Xxxxxxxxxxxx zdravotnictví podle §80 xxxx. 1 xxxx. x) xxxxxx x. 258/2000 Xx., x ochraně xxxxxxxxx xxxxxx x x xxxxx některých xxxxxxxxxxxxx xxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xx xxxxxxx xxxxxxxxxx Xxxxxxx imunizační xxxxxx xxxxxxxxx xxxxxxx očkovacích xxxxx pro xxxxxxxxxx, xxxxxxxx a mimořádná xxxxxxxx xxx rok 2014:
1. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx xxxxxxxx
1x) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému kašli (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX):
Xxxxxxxxx xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxx proteinum
Diphtheriae xxxxxxxxxx
Xxxxxx xxxxxxxxxx min.
Antigenum xxxxxxxxx xxxxxxxxxxx X xxxxxxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3
Xxxxxxxxxx Xxx: Polyribosylribitoli xxxxxxxx Xxxxxxxxxxx xxxxxxxxxx x, Xxxxxx anatoxinum
NEBO
1aa) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (inaktivovaná xxxxx), xxxxxx hepatitidě B, xxxxxxx vyvolaným Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX)
Xxxxxxxxxxx xxxxxxxxxx
Xxxxxx xxxxxxxxxx
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx
Xxxxx Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)
xxxxx 1 (Mahoney)
typus 2 (XXX-1)
xxxxx 3 (Xxxxxxx)
Xxxxxxxxx xxxxxxxxx xxxxxxxxxx X
Xxxxxxxxxxx xxxxxxxxxx typu x xxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx phasphas)
conjugata xxx xxxxxx xxxxxxxxxx
1x) očkovací xxxxx proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx (XXxX):
Xxxxxxxxxxx xxxxxxxxxx ≥ 30 xxxxxxxxxxxxx xxxxxxxx
Xxxxxx xxxxxxxxxx ≥ 40 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (FHA) 25 xxxxxxxxxx
Xxxxxxxxxxx (69xX) 8 xxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxx x (XXxXXxx):
| &xxxx;
Xxxxxxxxxxx anatoxinum
|
min. 30 xxxxxxxxxxxxx xxxxxxxx
|
| &xxxx;
Xxxxxx anatoxinum
|
min. 40 mezinárodních jednotek
|
|
Pertussis xxxxxxxxxx (PT)
|
25 mikrogramů
|
|
Pertussis xxxxxxxxxxxxxxx filamentosum (XXX)
|
&xxxx;
25 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxxxx (69kD)
|
8 mikrogramů
|
|
Haemophilus xxxxxxxxxx B
|
10 xxxxxxxxxx
|
| &xxxx;
xxx xxxxxxxxx tetanico
|
20-40 xxxxxxxxxx
|
1x) xxxxxxxx xxxxx xxxxx xxxxxxx x tetanu - xxxxxxxxx:
Xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxx ... min. 30 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxxx xxxxxx xxxxxxxxxxx ... xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxxx vyvolaným Xxxxxxxxxxx influenzae typ x:
1 dávka xxxxxxxxxxxxx xxxxxxx obsahuje: Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (30 xxxxxxxxxx).
1x) xxxxxxxx xxxxx xxxxx xxxxxx:
Xxxxxx anatoxinum ... xxx. 40 mezinárodních xxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx 15 xxx věku:
Antigenum xxxxxxxxx xxxxxxxxxxx X ... 10 xxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X od 16 xxx x xxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X ... 20 xxxxxxxxxx
1xx) xxxxxxxx xxxxx xxxxx spalničkám, příušnicím x xxxxxxxxx:
Xxxxxxxxxxx virus xxxxxxxxxx (Xxxxxxx) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx kulturu50
Parotitidis xxxxx xxxxxxxxxx (XXX 4385) xxx. 103,7 xxxxxxxx xxxxx xxx xxxxxxxx kulturu50
Rubeolae xxxxx xxxxxxxxxx (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx50
1x) xxxxxxxx xxxxx xxxxx dětské xxxxxxxx xxxxx x xxxxxxxxxxxx formě:
Virus poliomyelitis xxxxxxxxxxx typus 1 (Xxxxxxx) ... 40 xxxxxxxxxxx D xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2 (XXX-1) ... 8 antigenních X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 3 (Xxxxxxx) ... 32 xxxxxxxxxxx X xxxxxxxx*
* nebo xxxxxxxx xxxxxxxxxxxxxx antigenů xxxxxxxxx xxxxxx xxxxxx xxxxxxxxxxxxx metody.
1j) xxxxxxxx xxxxx xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxxxxxx xxxxxxx:
Xxxxxxxxxxxxxxx Xxxxxxxxxxxx xxxxxxxxxx xxxxx:
1, 2, 3, 4, 5, 6X, 7F, 8, 9X, 9V, 10X, 11A, 12X, 14, 15X, 17X, 18X, 19X, 19X, 20, 22X, 23X, 33X ... 25 xxxxxxxxxx z každého xxxxxxxx
1x) xxxxxxxx látka xxxxxxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 1
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 3
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 4
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 5
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7X
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 9X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 14
Xxxxxxxxxxxxx polysaccharidum sérotypus 18X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X
1xx) očkovací xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
| &xxxx;
Xxxxxxxxxxx xxxxxxxxxx
|
&xxxx;
xx xxxx xxx 2 xxxxxxxxxxx jednotky
|
|
Tetani xxxxxxxxxx
|
&xxxx;
xx méně xxx 20 mezinárodních xxxxxxxx
|
Xxxxxxxxx xxxxxxxx:
| &xxxx;
Xxxxxxxxx anatoxinum
|
8 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx
|
&xxxx;
8 mikrogramů
|
|
Pertaktin
|
2,5 xxxxxxxxxx
|
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:
| &xxxx;
xxxxx 1 (xxxx Xxxxxxx)
|
&xxxx;
40 X xxxxxxxx xxxxxxxx
|
| &xxxx;
xxxxx 2 (xxxx MEF-1)
|
8 X xxxxxxxx xxxxxxxx
|
| &xxxx;
xxxxx 3 (xxxx Xxxxxxx)
|
&xxxx;
32 X xxxxxxxx antigenu
|
NEBO
1lb) xxxxxxxx xxxxx proti xxxxxxx, dávivému kašli (xxxxxxxxxx xxxxx), tetanu, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx):
| &xxxx;
Xxxxxxxxxx toxoid
|
více xxxx rovno 2 xxxxxxxxxxx xxxxxxxx (2 Xx)
|
| &xxxx;
Xxxxxxxxx xxxxxx
|
&xxxx;
xxxx xxxx xxxxx 20 mezinárodních xxxxxxxx (5 Xx)
|
Xxxxxxxxx xxxxxxxx:
| &xxxx;
Xxxxxxxxx toxoid
|
2,5 mikrogramu
|
|
Filamentózní xxxxxxxxxxxx
|
&xxxx;
5 xxxxxxxxxx
|
| &xxxx;
Xxxxxxx xxxx 2+3
|
&xxxx;
5 xxxxxxxxxx
|
| &xxxx;
Xxxxxxxxx
|
&xxxx;
3 xxxxxxxxxx
|
| &xxxx;
Xxxxx xxxxxxxxxxxxx typu 1 (xxxxxxxxxxxx)
|
&xxxx;
40 antigenních X xxxxxxxx
|
| &xxxx;
Xxxxx xxxxxxxxxxxxx xxxx 2 (inaktivovaný)
|
8 xxxxxxxxxxx X jednotek
|
|
Virus poliomyelitis xxxx 3 (xxxxxxxxxxxx)
|
&xxxx;
32 xxxxxxxxxxx D xxxxxxxx
|
1x) xxxxxxxx xxxxx xxxxx xxxxxxxxxxx:
Xxxxxxxx Calmette Xxxxxx (xxxxxxxxxx) 100 000 - 300&xxxx;000 V.U.*
(kmen Xxxxxxxxxx 1331)
*X.X. = živé xxxxxxx
1x) očkovací látka xxxxx virové hepatitidě X pro xxxxx xxxxxxxx xx dialyzačního xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X xxxxxxxxxxxxxx 20 xxxxxxxxxx; adjuvans XX04X xxxxxxxxxx 3-O-deacyl-4-monofosforyl-lipid X (XXX) 50 xxxxxxxxxx x 1 xxxxx
2. Xxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxx xxxxxxxx
2x) očkovací látka xxxxx virové xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:
Antigenum xxxxxxxxx hepatitidis B ... 20 xxxxxxxxxx
2x) xxxxxxxx xxxxx proti xxxxxxxxx
Xxxxx xxxxxx xxxxxxxxxxx (xxxx Xxxxxx rabies XX/XX 38&xxxx;1503-3X xxxx xxxx rovno 2,5 xxxxxxxxxxxxx jednotek v 1 xxxxx (0,5 xx)
2x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
3. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx mimořádná očkování
3a) xxxxxxxx látka proti xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:
Xxxxxxxxx A xxxxx xxxxxxxxxxx
3x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx X ve xxxxxxx xxx xxxx:
Xxxxx hepatitis X xxxxxxxxxxx
Xxxxxxx:
xxx. MUDr. Xxxxx, CSc., v. x.
Xxxxxxxxx
Xxxxxx xxxxxxx č. 195/2013 Xx. xxxxx xxxxxxxxx xxxx 27.7.2013.
Ke xxx xxxxxxxx xxxxxx xxxxxxx xxxxx xxxxx či xxxxxxxxx.
Znění xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx netýká derogační xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.